Innovation Pharmaceuticals Inc (IPIX)

[John B]

BK, or others, please give me your viewpoint on this.
I think the recent SP softness has a lot to do with $.

I think if CTIX had $20 million in the bank and then
bought Polym and announced a bigger more expensive
Pur Trial, and other new trials for next year, the SP
would have took off.

We spent 2 million of our Aspire money that could have
been used on P and K trials. The POC could have given
us a early license that would have provide $ to finish
up future trials.

Obviously management knows all this. They are saying
no future dilution. Maybe they are going to throw more
assets into the CTIX pie because of confidence in K.
If they do this the SP will take off IMO.

Look at how the Aspire deal last year triggered a huge
run up in the stock. It got rid of a lot of uncertainty
on how future trials were going to be paid for.
We maybe at that same point again.

I have seen some posts throwing some big numbers around,
like this trial will cost 5 million, this other trial will
cost 5 million, etc...

So my question is, and maybe Karin can ask in the interview:

How does spending money on Polymedix, give us more financial strength to afford more trials, and more costly trials (P)
without causing dilution?